Cargando…

Toxic Bradycardias in the Critically Ill Poisoned Patient

Cardiovascular drugs are a common cause of poisoning, and toxic bradycardias can be refractory to standard ACLS protocols. It is important to consider appropriate antidotes and adjunctive therapies in the care of the poisoned patient in order to maximize outcomes. While rigorous studies are lacking...

Descripción completa

Detalles Bibliográficos
Autor principal: Givens, Melissa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321542/
https://www.ncbi.nlm.nih.gov/pubmed/22545217
http://dx.doi.org/10.1155/2012/852051
_version_ 1782228958081712128
author Givens, Melissa L.
author_facet Givens, Melissa L.
author_sort Givens, Melissa L.
collection PubMed
description Cardiovascular drugs are a common cause of poisoning, and toxic bradycardias can be refractory to standard ACLS protocols. It is important to consider appropriate antidotes and adjunctive therapies in the care of the poisoned patient in order to maximize outcomes. While rigorous studies are lacking in regards to treatment of toxic bradycardias, there are small studies and case reports to help guide clinicians' choices in caring for the poisoned patient. Antidotes, pressor support, and extracorporeal therapy are some of the treatment options for the care of these patients. It is important to make informed therapeutic decisions with an understanding of the available evidence, and consultation with a toxicologist and/or regional Poison Control Center should be considered early in the course of treatment.
format Online
Article
Text
id pubmed-3321542
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33215422012-04-27 Toxic Bradycardias in the Critically Ill Poisoned Patient Givens, Melissa L. Emerg Med Int Review Article Cardiovascular drugs are a common cause of poisoning, and toxic bradycardias can be refractory to standard ACLS protocols. It is important to consider appropriate antidotes and adjunctive therapies in the care of the poisoned patient in order to maximize outcomes. While rigorous studies are lacking in regards to treatment of toxic bradycardias, there are small studies and case reports to help guide clinicians' choices in caring for the poisoned patient. Antidotes, pressor support, and extracorporeal therapy are some of the treatment options for the care of these patients. It is important to make informed therapeutic decisions with an understanding of the available evidence, and consultation with a toxicologist and/or regional Poison Control Center should be considered early in the course of treatment. Hindawi Publishing Corporation 2012 2012-04-01 /pmc/articles/PMC3321542/ /pubmed/22545217 http://dx.doi.org/10.1155/2012/852051 Text en Copyright © 2012 Melissa L. Givens. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Givens, Melissa L.
Toxic Bradycardias in the Critically Ill Poisoned Patient
title Toxic Bradycardias in the Critically Ill Poisoned Patient
title_full Toxic Bradycardias in the Critically Ill Poisoned Patient
title_fullStr Toxic Bradycardias in the Critically Ill Poisoned Patient
title_full_unstemmed Toxic Bradycardias in the Critically Ill Poisoned Patient
title_short Toxic Bradycardias in the Critically Ill Poisoned Patient
title_sort toxic bradycardias in the critically ill poisoned patient
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321542/
https://www.ncbi.nlm.nih.gov/pubmed/22545217
http://dx.doi.org/10.1155/2012/852051
work_keys_str_mv AT givensmelissal toxicbradycardiasinthecriticallyillpoisonedpatient